[Behçet's disease].
Fujino
Yujiro
Y
Division of Ophthalmology, Tokyo Kosei Nenkin Hospital.
D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D015235:HLA-B Antigens / Q000235:genetics; D059949:HLA-B51 Antigen; D006360:Heat-Shock Proteins; D006801:Humans; D000069285:Infliximab; D007564:Japan / Q000453:epidemiology; D008297:Male; D011379:Prognosis; D012015:Reference Standards; D012737:Sex Factors; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D015235:HLA-B Antigens; D059949:HLA-B51 Antigen; D006360:Heat-Shock Proteins; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab